Cancer Biopharmaceuticals

Cancer
Cancer Biopharmaceuticals
Tumor-Specific Cancer Immunotherapies

A Closer Look at Tscan Therapeutics (TCRX): Driving Advancements in TCR-T Cell Therapy for Cancer

Tscan Therapeutics Inc (TCRX) is a biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company’s proprietary platform identifies novel TCR targets and engineers TCRs directed against these targets for use in TCR-T cell therapies. These therapies aim to harness the power of the […]

Read More
Cancer
Cancer Biopharmaceuticals

Cardiff Oncology (CRDF): A Biotech Gem in the Fight Against Cancer

Cardiff Oncology Inc. (CRDF) is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company’s primary objective is to leverage its expertise in oncology and drug development to create therapies that can address unmet medical needs and improve the lives of patients battling cancer. Three main drivers of growth for Cardiff Oncology […]

Read More
Biomedical
Cancer Biopharmaceuticals

Janux Therapeutics (JANX): The Biotech Innovator Pioneering Next-Gen Cancer Therapies

Janux Therapeutics Inc (JANX) is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The company aims to harness the power of the immune system to target and eliminate cancer cells. Their approach involves creating novel therapeutics that can stimulate the body’s immune response against tumors, potentially leading to improved outcomes for patients with various […]

Read More
Cancer
Cancer Biopharmaceuticals
Tumor-Specific Cancer Immunotherapies

Innovative Cancer Treatments: How Verastem (VSTM) is Changing the Game

Verastem, Inc. (VSTM) is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem’s mission is to improve the lives of patients suffering from cancer by targeting the underlying biology of cancer stem cells, […]

Read More
Cancer
Cancer Biopharmaceuticals
TradersPro Saturday

Nkarta Inc (NKTS): Leading the Charge in Next-Generation Cancer Therapies

Nkarta Inc (NKTS) is a biotechnology company focused on the research, development, and commercialization of natural killer (NK) cell therapies for the treatment of cancer. NK cells are a type of immune cell that can identify and destroy cancerous or infected cells in the body. Nkarta’s innovative approach involves harnessing and enhancing the innate power […]

Read More
Cancer
Cancer Biopharmaceuticals

Immunome: A New Era in Cancer Research

Immunome, Inc. (IMNM) is a biopharmaceutical company primarily engaged in discovering and developing antibody therapeutics. The company focuses on treatments for oncology and infectious diseases. Its lead oncology program is IMM-ONC-01, which targets IL-38, a tumor-derived immune checkpoint that helps tumors evade the immune system. Additionally, Immunome is developing IMM-BCP-01, an antibody cocktail aimed at […]

Read More
Biopharmaceuticals
Cancer Biopharmaceuticals
Daily Rundown
Software
Tech Services

Tech Services, Biopharma, Cancer, Software

FingerMotion, Inc. (FNGR) FingerMotion, Inc., a mobile data specialist company, provides mobile payment and recharge platform system in China. Nuvalent, Inc. (NUVL) Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Immunovant, Inc. (IMVT) Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of […]

Read More
Biopharmaceuticals
Cancer Biopharmaceuticals
Immunology Biopharmaceutical
Value Investing
Value Stocks

GILD is down about -15% since the end of 2022. Is it a good bargain yet?

No matter how much the world moves away from COVID-19, the truth is that it isn’t going away. The move by government entities as well as healthcare organizations around the world to “endemic” phase protocols doesn’t mean the disease has been eradicated. It really means that the disease is acknowledged as a permanent part of […]

Read More
Biomedical
Biotech
Biotechnology
Cancer Biopharmaceuticals
Trade Of The Day

$2 Biotech Stock To Buy Now

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. ONCY $1.7400 0.1300 % 8.0700 Oncolytics Biotech Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.07% Wk: 7.41% Mo: 48.72% Yrly: 55.36% […]

Read More
Biopharmaceuticals
Biotechnology
Cancer Biopharmaceuticals
Value Investing
Value Stocks

GILD is up 8% from its 52-week low. Where is its bargain price?

No matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores more than two years ago, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names […]

Read More
Biopharmaceuticals
Cancer Biopharmaceuticals
Trade Of The Day

Everything You Need To Know Now About CTI BioPharma Corp. (CTIC)

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $4.9300 0.1200 % 2.4900 Cti Biopharm Corp […]

Read More
Biological Drug Manufacturing
Biopharmaceuticals
Biotechnology
Cancer
Cancer Biopharmaceuticals
Cash
Coronavirus
COVID-19
COVID-19 Pill
Defensive Stocks
Dividend Stocks
Dividend Yields
Dividends
Drug Development
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Fundamentals
Oncology
Pharmaceuticals
Technical Analysis
Valuations
Value Investing
Value Stocks

MRK is up about 14% from its December low. Is it a good time to buy?

As I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]

Read More
Cancer
Cancer Biopharmaceuticals
Daily Rundown
Home Furnishings
Oil Royalty Trust
Plush Animal Retailer
Semiconductor

Semiconductors, Plush Animals, Oil Royalty Trust, Furniture, Cancer Medication

Aehr Test Systems (AEHR) Aehr Test Systems primarily designs, engineers, manufactures, and sells test and burn-in equipment for use in the semiconductor industry in North America, Asia, and Europe. It provides full wafer contact test systems, test during burn-in systems, test fixtures, and related accessories. The company offers Advanced Burn-in and Test System family of […]

Read More
Biotech
Cancer
Cancer Biopharmaceuticals
Coronavirus
COVID-19
Dividends
Economy
Fibonacci Retracement
Fundamental Analysis
HeathCare
Immunology Biopharmaceutical
Immunotherapies
Pharmaceuticals
RNA Biotechnology
Technical Analysis
Tumor-Specific Cancer Immunotherapies
Vaccines
Value Investing
Value Stocks

PFE is down about 20% in the last three months, and that’s a good thing for value-focused investors

As recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]

Read More
Autoimmune Diseases
Cancer
Cancer Biopharmaceuticals
One Hot Stock

Immutep Limited (IMMP) – Buy Price: $4.40 or better

Buy Price: $4.40 or better Sell Price: TradersPro Sell Signal Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ‘eftilagimod alpha’ or ‘efti’, which is a recombinant […]

Read More

Best Stocks With Perfect Trade Setups

X